Cargando…
Adherence to long-term oxygen therapy in patients with chronic obstructive pulmonary disease
Long-term oxygen therapy (LTOT) has beneficial effects on survival in patients with chronic obstructive pulmonary disease (COPD) and severe hypoxemia at rest. Two landmark trials suggested that these benefits depend on the time of exposure to oxygen. Patients are usually prescribed LTOT for at least...
Autores principales: | Gauthier, Amélie, Bernard, Sarah, Bernard, Emmanuelle, Simard, Serge, Maltais, François, Lacasse, Yves |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302966/ https://www.ncbi.nlm.nih.gov/pubmed/29631423 http://dx.doi.org/10.1177/1479972318767724 |
Ejemplares similares
-
Multi-center, randomized, placebo-controlled trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease: a study protocol for the INOX trial
por: Lacasse, Yves, et al.
Publicado: (2017) -
Oximetry neither to prescribe long-term oxygen therapy nor to screen for severe hypoxaemia
por: Lacasse, Yves, et al.
Publicado: (2021) -
Short-Term Oxygen Therapy Outcomes in COPD
por: Soumagne, Thibaud, et al.
Publicado: (2022) -
Automated oxygen titration and weaning with FreeO(2) in patients with acute exacerbation of COPD: a pilot randomized trial
por: Lellouche, François, et al.
Publicado: (2016) -
Patient registries for home oxygen research and evaluation
por: Lacasse, Yves, et al.
Publicado: (2019)